Background
Case presentation
Clinical history
Pathologic findings
Macroscopic findings
Microscopic findings
Immunohistochemical features
Marker | Neuroendocrine Tissue | Glandular Epithelium | Stromal Tissue | Neuroepithelium |
---|---|---|---|---|
SALL4 | + (focal) | + | – | + (focal) |
Glypican-3 | + (focal) | + | – | + (focal) |
Oct-4 | – | – | – | – |
S-100 | – | – | – | – |
PLAP | – | – | – | – |
NSE | + | – | – | + |
Neurofilament | + (focal) | – | – | – |
GFAP | – | – | – | – |
CD56 | + | + | – | + |
CD57 | + | – | + | + |
CD99 | + | + | + | + |
Synaptophysin | + | – | – | + |
Chromogranin A | – | – | – | – |
AFP | – | – | – | – |
TTF-1 | – | – | – | – |
CDX-2 | – | + (focal) | – | – |
WT1 | – | + (focal) | – | – |
ER | – | – | – | – |
CD10 | – | – | – | – |
PAX-8 | +(focal) | + | + | +(focal) |
β-catenin | – | +(membrane) | – | – |
AE1/AE3 | – | + | – | – |
CD34 | – | – | + | – |
Desmin | – | – | + in STMC | – |
α-SMA | – | – | – | – |
MyoD1 | – | – | + in STMC | – |
Cytogenetic analysis with FISH
Discussion
Author [year] | Age, y | Primary | Diagnosis | Treatment | Stage | Histology | Outcome |
---|---|---|---|---|---|---|---|
Ehrmann RL [1990] | 62 | Ovary | TCS | Surgery + chemotherapy | III | SCC, adenocarcinoma, chondrosarcoma, rhabdomyosarcoma | DOD 27 mo |
Tanimoto A [2001] | 59 | Ovary | TCS | Surgery | IV | SCC, adenocarcinoma, chondrosarcoma | DOD |
Garcia-Garvis OF [2008] | 69 | Ovary | TCS | Surgery | IV | SCC, adenocarcinoma, chondrosarcoma, rhabdomyosarcoma, osteosarcoma, liposarcoma, yolk-sac tumor | DOD |
Matsuura Y [2010] | 40 | Ovary | TCS | Surgery + chemotherapy | II | Adenocarcinoma, chondrosarcoma, endometrial stromal sarcoma | DOD 46 mo |
Coutney F [2019] | 55 | Ovary | TCS | Surgery + chemotherapy | IC | Adenocarcinoma, carcinosarcoma, dysgerminoma, primitive retinal tissue primitive neuroepithelial tissue, fetal cartilage | DOD 14 mo |
Present case [2019] | 45 | Cervix | TCS | Surgery + radiation | IB2 | Glial-like tissues, immature intestinal glands, cartilage, neuroepithelial tissue, rhabdomyosarcoma | NED 13 mo |